Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1019 of 1,261
  1. US 7615566

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  2. US 7612188

    Modified vitamin K. dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  3. US 7612107

    Treatment and inhibition of disease conditions using flexible heteroarotinoids

    The Board of Regents of the University of Oklahoma · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  4. US 7612203

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  5. US 7612044

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  6. US 7611693

    Mechanism-based targeted pancreatic beta cell imaging and therapy

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  7. US 7612093

    Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

    United Therapeutics Corporation · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  8. US 7612091

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  9. US 7612065

    Inhibitors of c-JUN N-terminal kinases (JNK)

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  10. US 7611532

    Coated implantable medical device

    Cook Regentec LLC · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  11. US 7612073

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  12. US 7612064

    Sulfopyrroles

    Takeda Pharmaceutical Company Limited · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  13. US 7612037

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  14. US 7611885

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  15. US 7611722

    Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  16. US 7611704

    Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  17. US 7611728

    Osmotic delivery of therapeutic compounds by solubility enhancement

    Supernus Pharmaceuticals, Inc. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  18. US 7611533

    Coated implantable medical device

    Cook Regentec LLC · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  19. US 7608641

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  20. US 7608683

    Stress proteins and peptides and methods of use thereof

    The Regents of the University of California · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  21. US 7608627

    6-azaindole compound

    Takeda Pharmaceutical Company Limited · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  22. US 7608422

    Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  23. US 7608261

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  24. US 7608272

    Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.